Are IJT and XBI in the same category?

IJT is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.

Which returned more over the last year, IJT or XBI?

In the year to Oct 28, 2026, with distributions reinvested, IJT returned +15.4% and XBI +41.2%.

Which is cheaper, IJT or XBI?

IJT is cheaper, by 0.17 percentage points a year. That is about $17 on $10,000 held for a year. Fees come from each fund's prospectus.

How much do IJT and XBI overlap with the S&P 500?

By their latest filed holdings, 0% of IJT and 13% of XBI by weight is stocks the S&P 500 already holds.

Data as of Oct 28, 2026.

Across categories

IJT vs XBI: Differences, Returns & Fees

Share on X Download as PDF

Over the year to Oct 28, 2026, IJT returned +15.4% to XBI's +41.2%, and IJT charges 0.18% to XBI's 0.35%.

askIQ about this page

askIQ about IJT and XBI

Net assets on Oct 27, 2026: $7.5bn for iShares S&P Small-Cap 600 Growth ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

IJT on its own →XBI on its own →

At a glance

+15.4%

IJT total return, 1 year

+41.2%

XBI total return, 1 year

0.18%

IJT expense ratio

0.35%

XBI expense ratio

Pair scorecard

IJT costs 0.17 points a year less; their one-year returns differ by 25.8 points; XBI is 1.4 times larger.

IJT vs XBI: Differences, Returns & Fees
Measure	IJT	XBI
Return
Measure	IJT	XBI
Total return, 1 year	+15.4%	+41.2%
Drawdown
Measure	IJT	XBI
Below its high	8.2%, high on Aug 4, 2026
Below its all-time high		8.9%, high on Feb 8, 2021
Benchmark
Measure	IJT	XBI
What it tracks	S&P SmallCap 600 Growth Index	Biotech
Cost and size
Measure	IJT	XBI
Expense ratio	0.18%	0.35%
Net assets, as of Oct 27, 2026	$7.5bn	$10.3bn
Active share vs the S&P 500		98%
Holdings
Measure	IJT	XBI
Holdings in common	6%
Top ten holdings, share of the fund	9.6%	18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

By the books each fund has filed, IJT and XBI hold 6% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

50%

0 half 100%

half

6% in common

Positions both hold · largest shared weight first IJT XBI

PROTAGONIST THERAPEUTICS 1.11% 1.42%

TG THERAPEUTICS 0.97% 1.51%

ALKERMES 0.90% 1.43%

PTC THERAPEUTICS 0.63% 1.34%

VERACYTE 0.49% 1.16%

ARCUTIS BIOTHERAPEUTICS 0.44% 0.95%

ACADIA PHARMACEUTICALS 0.32% 0.49%

ADMA BIOLOGICS 0.30% 0.50%

VERICEL 0.27% 0.47%

SAREPTA THERAPEUTICS 0.15% 0.55%

ARCUS BIOSCIENCES 0.15% 0.37%

VIR BIOTECHNOLOGY 0.07% 0.29%

Only in one fund ↓

Only in IJT

VIASAT INC 1.18%

RYMAN HOSPITALITY PROPERTIES REIT 1.10%

ETSY 0.91%

GLAUKOS 0.90%

ZURN ELKAY WATER SOLUTIONS CORP 0.88%

FEDERAL SIGNAL CORP 0.86%

ARMSTRONG WORLD INDUSTRIES 0.80%

LYFT CLASS A 0.77%

Only in XBI

MODERNA INC 2.24%

TWIST BIOSCIENCE CORP 1.86%

NATERA INC 1.82%

BIOGEN INC 1.75%

HALOZYME THERAPEUTICS INC 1.75%

UNITED THERAPEUTICS CORP 1.71%

AMGEN INC 1.68%

ABBVIE INC 1.67%

Check overlap with more funds →

Side by side

IJT iShares S&P Small-Cap 600 Growth ETF XBI State Street SPDR S&P Biotech ETF

Where it sits Stock ETF Thematic ETF

Issuer iShares State Street

What it is Tracks the S&P Small-Cap 600 Growth Biotech

Total return, 1 year +15.4% +41.2%

Its benchmark over the same days +15.6% (SLYG) not measured

Gap to its benchmark −0.2 pts vs SLYG not measured

Expense ratio 0.18% 0.35%

Already in the S&P 500 0.0% 13.2%

Holdings 369 165

Net assets, as of Oct 27, 2026 $7.5bn $10.3bn

IJT and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

About each fund

IJT

IJT tracks the S&P Small-Cap 600 Growth. Over the year to Oct 28, 2026 it returned +15.4% with distributions reinvested, against +15.6% for its benchmark, the S&P SmallCap 600 Growth Index. The prospectus expense ratio is 0.18% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 369 positions, with the top ten at 9.6%. It sat 8.2% below its high of Aug 4, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are IJT and XBI in the same category?: IJT is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IJT or XBI?: In the year to Oct 28, 2026, with distributions reinvested, IJT returned +15.4% and XBI +41.2%.
Which is cheaper, IJT or XBI?: IJT is cheaper, by 0.17 percentage points a year. That is about $17 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IJT and XBI overlap with the S&P 500?: By their latest filed holdings, 0% of IJT and 13% of XBI by weight is stocks the S&P 500 already holds.

Other comparisons

IBB vs IJT DYNF vs IJT BITO vs IJT BNDX vs IJT VTWO vs XBI IWC vs XBI IWM vs XBI IJR vs XBI

Where to next

IJT on its own →XBI on its own →Hold both: look the portfolio through →Rankings →IJT dividend history →IJT holdings →XBI dividend history →XBI holdings →Standards and sources →

Sources and dates

IJT filings on SEC EDGAR ↗

IJT prospectus with the expense ratio (SEC) ↗

iShares page for IJT ↗

XBI filings on SEC EDGAR ↗

XBI prospectus with the expense ratio (SEC) ↗

State Street website ↗

Links are sources, not endorsements. A comparison is not a recommendation.

How this is computed

Overlap adds up the smaller of the two weights for each security both funds hold.

Cite this pageCitation, APA and Markdown

ETFIQ, IJT against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/ijt-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.